CME Group Inc. $CME Stock Sold by Curated Wealth Partners LLC

Curated Wealth Partners LLC decreased its stake in shares of CME Group Inc. (NASDAQ:CME) by 99.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,357 shares of the financial services provider’s stock after selling 655,278 shares during the period. Curated Wealth Partners LLC’s holdings in CME Group were worth $879,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. BlackRock Inc. acquired a new stake in shares of CME Group in the 2nd quarter worth approximately $6,749,965,000. Bank of New York Mellon Corp acquired a new position in shares of CME Group during the second quarter valued at approximately $867,313,000. Alphabet Inc. acquired a new position in shares of CME Group during the second quarter valued at approximately $769,376,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in CME Group during the second quarter worth approximately $629,771,000. Finally, Bank of America Corp DE bought a new stake in CME Group during the second quarter worth approximately $622,679,000. 87.75% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on CME shares. Wells Fargo & Company upped their target price on CME Group from $301.00 to $315.00 and gave the stock an “overweight” rating in a research report on Wednesday. Wall Street Zen upgraded CME Group from a “strong sell” rating to a “sell” rating in a research report on Saturday, October 3rd. Weiss Ratings upgraded CME Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Piper Sandler dropped their price objective on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 15th. Finally, Morgan Stanley boosted their price objective on CME Group from $330.00 to $337.00 and gave the stock an “overweight” rating in a research note on Friday, October 9th. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, CME Group has an average rating of “Hold” and an average price target of $292.94.

CME Group Price Performance

Shares of NASDAQ CME opened at $289.46 on Friday. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a 50-day moving average of $273.52 and a two-hundred day moving average of $270.60. The company has a market capitalization of $104.08 billion, a price-to-earnings ratio of 24.55, a PEG ratio of 3.74 and a beta of 0.24.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business’s revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.96 EPS. As a group, analysts expect that CME Group Inc. will post 12.29 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Wednesday, September 9th were paid a dividend of $1.30 per share. The ex-dividend date of this dividend was Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio is currently 44.11%.

Insider Activity at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 15,000 shares of CME Group stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $274.44, for a total value of $4,116,600.00. Following the transaction, the chief executive officer owned 40,630 shares in the company, valued at approximately $11,150,497.20. The trade was a 26.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director William R. Shepard purchased 293 shares of the firm’s stock in a transaction on Friday, September 25th. The stock was acquired at an average price of $268.76 per share, for a total transaction of $78,746.68. Following the transaction, the director owned 263,289 shares of the company’s stock, valued at $70,761,551.64. The trade was a 0.11% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.

The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.

CME Group’s history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.